Press Releases

Please click here if you wish to receive an e-mail notification regarding Alector press releases.

Dec 06, 2019
Alector Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) Meeting
Dec 05, 2019
Alector Announces FDA Fast Track Designation Granted to AL001 for the Treatment of Patients with Frontotemporal Dementia
Jul 17, 2019
Alector Announces Data from On-going Phase 1b Trial Demonstrating that AL001 Reverses Progranulin Deficiency in Frontotemporal Dementia Patients
Displaying 1 - 10 of 19